• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Catalent Completes RheinCell Therapeutics Acquisition contractpharma
    August 05, 2021
    ​Catalent has completed the acquisition of RheinCell Therapeutics GmbH, a developer and manufacturer of GMP-grade human induced pluripotent stem cells (iPSCs).
  • Catalent to Acquire RheinCell Therapeutics contractpharma
    June 28, 2021
    Catalent, a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, has reached an agreement to acquire RheinCell Therapeutics GmbH ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service